M.K. Brenner

1.1k total citations
31 papers, 616 citations indexed

About

M.K. Brenner is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, M.K. Brenner has authored 31 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Immunology and 11 papers in Genetics. Recurrent topics in M.K. Brenner's work include Virus-based gene therapy research (10 papers), CAR-T cell therapy research (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). M.K. Brenner is often cited by papers focused on Virus-based gene therapy research (10 papers), CAR-T cell therapy research (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). M.K. Brenner collaborates with scholars based in United States, United Kingdom and Australia. M.K. Brenner's co-authors include HE Heslop, Patricia Yotnda, Helen E. Heslop, H E Heslop, George Carrum, André Lieber, Alan R. Davis, Cliona M. Rooney, Dmitry M. Shayakhmetov and Catherine M. Bollard and has published in prestigious journals such as The Journal of Immunology, British Journal of Cancer and Transplantation.

In The Last Decade

M.K. Brenner

31 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.K. Brenner United States 14 241 221 185 169 166 31 616
M. Alcorn United Kingdom 14 195 0.8× 420 1.9× 130 0.7× 131 0.8× 144 0.9× 23 678
Lujia Dong China 10 340 1.4× 428 1.9× 94 0.5× 94 0.6× 239 1.4× 34 748
S Cayeux Germany 17 413 1.7× 299 1.4× 246 1.3× 249 1.5× 542 3.3× 25 963
G Tricot United States 8 192 0.8× 298 1.3× 47 0.3× 145 0.9× 112 0.7× 21 550
Martin Göerner Germany 15 230 1.0× 315 1.4× 151 0.8× 219 1.3× 177 1.1× 33 730
T Grünberger Canada 14 203 0.8× 418 1.9× 106 0.6× 258 1.5× 330 2.0× 26 960
Masuji Yamamoto Japan 9 239 1.0× 373 1.7× 88 0.5× 104 0.6× 162 1.0× 19 574
Barbara H. Barendregt Netherlands 14 73 0.3× 103 0.5× 147 0.8× 176 1.0× 389 2.3× 18 674
Jörg Schüttrumpf Germany 14 99 0.4× 166 0.8× 124 0.7× 205 1.2× 135 0.8× 39 588
Heidrun Boztug Austria 13 85 0.4× 208 0.9× 137 0.7× 81 0.5× 219 1.3× 24 529

Countries citing papers authored by M.K. Brenner

Since Specialization
Citations

This map shows the geographic impact of M.K. Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.K. Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.K. Brenner more than expected).

Fields of papers citing papers by M.K. Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.K. Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.K. Brenner. The network helps show where M.K. Brenner may publish in the future.

Co-authorship network of co-authors of M.K. Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of M.K. Brenner. A scholar is included among the top collaborators of M.K. Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.K. Brenner. M.K. Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gerdemann, Ulrike, Anne Christin, Carolina Colli Cruz, et al.. (2010). Multi-Tumor-Antigen-Specific Cytotoxic T Lymphocytes For Therapy Of Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 16(2). S179–S179. 1 indexed citations
3.
Louis, Chrystal U. & M.K. Brenner. (2009). Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics. Current Pharmaceutical Design. 15(4). 424–429. 13 indexed citations
4.
Gottschalk, Stephen, Catherine M. Bollard, Karin Straathof, et al.. (2007). T Cell Therapies. PubMed. 69–82. 11 indexed citations
5.
Carrum, George, et al.. (2007). Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 39(11). 705–709. 57 indexed citations
6.
Popat, Uday, Helen E. Heslop, April Durett, et al.. (2006). Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML). Bone Marrow Transplantation. 37(6). 547–552. 13 indexed citations
7.
Carrum, George, Gary D. Myers, Catherine M. Bollard, et al.. (2005). Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab. Bone Marrow Transplantation. 36(9). 797–802. 41 indexed citations
8.
Huls, Helen, HE Heslop, John Schindler, et al.. (2005). Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation. Cytotherapy. 7(2). 116–125. 21 indexed citations
9.
Heslop, HE, Stephen Gottschalk, Catherine M. Bollard, et al.. (2004). Options for T‐cell based therapies. Vox Sanguinis. 87(s2). 230–234. 1 indexed citations
10.
Yotnda, Patricia, et al.. (2004). Comparison of the Efficiency of Transduction of Leukemic Cells by Fiber-Modified Adenoviruses. Human Gene Therapy. 15(12). 1229–1242. 37 indexed citations
11.
Yotnda, Patricia, HE Heslop, Dmitry M. Shayakhmetov, et al.. (2001). Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Therapy. 8(12). 930–937. 105 indexed citations
13.
Brenner, M.K., et al.. (1998). Gene and Cell Transfer for Specific Immunotherapy. Vox Sanguinis. 74(S2). 87–90. 9 indexed citations
14.
Horwitz, E.M., et al.. (1996). Treatment of severe osteogenesis imperfecta by allogeneic bone marrow transplantation. Matrix Biology. 15(3). 189–189. 4 indexed citations
15.
Brenner, M.K., H E Heslop, D. Rill, et al.. (1994). Gene Transfer and Bone Marrow Transplantation. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 691–697. 8 indexed citations
16.
Rill, D., Michael Buschle, Nicholas K. Foreman, et al.. (1992). Retrovirus-Mediated Gene Transfer as an Approach to Analyze Neuroblastoma Relapse after Autologous Bone Marrow Transplantation. Human Gene Therapy. 3(2). 129–136. 45 indexed citations
17.
Athanasou, N A, John F. Quinn, M.K. Brenner, et al.. (1990). Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation. British Journal of Cancer. 61(3). 385–389. 22 indexed citations
18.
Heslop, H E, et al.. (1989). Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia.. The Journal of Immunology. 143(11). 3828–3834. 38 indexed citations
19.
Brenner, M.K.. (1988). Leucocyte Typing III. White Cell Differentiation Antigens. Immunology. 64(1). 185. 3 indexed citations
20.
Brenner, M.K.. (1983). New Immunomodulating Agents and Biological Response Modifiers. Immunology. 50(3). 517. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026